Oruka Therapeutics, Inc. (ORKA) Insider Trading

Name: Oruka Therapeutics, Inc. (ORKA) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 13, 2026): Arjun Agarwal (Senior Vice President, Finance): Exercise/Conversion of 8,541 shares, $106.8K.

Get alerted when insiders trade ORKA

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta